The Videos

Features

Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry

Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022

Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

Aaron Bartlone, Chief Operating Officer | Cybin